Question

How long does stem cell therapy for Muscular Dystrophy last?

Durability must be established for the exact product. A short biomarker or strength change cannot show sustained preservation of muscle or function, and evidence from an authorised gene therapy cannot be transferred to an MSC product.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Muscular Dystrophy

Muscular dystrophies are a diverse group of inherited disorders, so diagnosis, affected gene, age, cardiac and respiratory status and disease stage determine appropriate care. Research spans gene replacement, exon skipping, gene editing, muscle progenitors and supportive-cell strategies. These mechanisms are different, and an MSC infusion does not correct an underlying pathogenic variant or reproduce an approved gene-targeted product.

Am I a candidate? → · Muscular Dystrophy: full overview → · Muscular Dystrophy cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information